Latest news
Akebia Therapeutics Price Target Announced at $1.00/Share by Leerink Partners - MoomooMoomoo · Sat, 08 Aug 2026 03:40:06 GMTLeerink Partners Adjusts Price Target on Cencora to $380 From $368 - MoomooMoomoo · Fri, 07 Aug 2026 13:00:35 GMTDoximity, Inc. : Leerink Partners Raises Targ - MoomooMoomoo · Fri, 07 Aug 2026 11:05:56 GMTLatigo: Goldman Sachs & Co. LLC, Jefferies, Leerink Partners and Guggenheim Securities Are Joint Book-Running Managers for the Offering >LTGO - MoomooMoomoo · Fri, 07 Aug 2026 00:06:00 GMTLeerink Partners Maintains GoodRx(GDRX.US) With Buy Rating, Announces Target Price $5 - MoomooMoomoo · Thu, 06 Aug 2026 22:47:21 GMTLeerink Partners Adjusts Price Target on AbbVie to $279 From $245 - MoomooMoomoo · Wed, 05 Aug 2026 15:30:35 GMTLeerink Partners Adjusts Price Target on Gilead Sciences to $130 From $126 - MoomooMoomoo · Wed, 05 Aug 2026 15:25:02 GMTLeerink Partners Adjusts PT on Henry Schein to $96 From $88, Maintains Market Perform Rating - MoomooMoomoo · Wed, 05 Aug 2026 12:24:44 GMT